Henry Gosebruch, Former AbbVie EVP and Chief Strategy Officer, Joins ACELYRIN, INC. Board of Directors

Veteran dealmaker and biopharma leader brings more than 25 years of global strategic partnering, business development and M&A experience LOS ANGELES, March 29, 2023 /PRNewswire/ — ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery…